A rare but severe pulmonary side effect of cetuximab in two patients

Cetuximab is a monoclonal antibody that treats malignant disease by inhibiting epidermal growth factor receptor. Many common adverse events have been reported and include skin rashes, infusion reactions, gastrointestinal complaints and headache. Up to now, cetuximab-associated pulmonary toxicity has...

Full description

Saved in:
Bibliographic Details
Published in:BMJ Case Rep
Main Authors: Achermann, Yvonne, Frauenfelder, Thomas, Obrist, Stefan, Zaugg, Kathrin, Corti, Natasha, Günthard, Huldrych F
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2012
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4560109/
https://ncbi.nlm.nih.gov/pubmed/22843749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-03-2012-5973
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items